Saturday, April 5, 2025

Yet to receive SEC communication on Sputnik V approval: DRL

Date:

Share post:

HYDERABAD: Amid reports that the subject expert committee (SEC) has approved Dr. Reddy’s Laboratories’ (DRL) application for the Russian vaccine candidate Sputnik V to tackle Coronavirus pandemic, the city-based company is yet to receive official communication about the approval.

“There is no approval received yet. We are still awaiting the statement from the SEC. Once we get something, we will release a statement,” a DRL official told IANS on Monday.

He said that the SEC has to first pass on the recommendation to the Drugs Controller General of India (DCGI) and then the latter has to give the nod.

The pharmaceutical major is expecting that this process might take a day or two.

When quizzed on the company’s preparedness to produce the vaccine in large numbers, the official said ‘we will be releasing details as and when we get some input there (from SEC and DCGI)’.

This development comes at a time when several Indian states are facing severe vaccine shortage and is a positive development.

Meanwhile, Dr. Reddy’s scrip rallied on the bourses, reacting to the approval news reports.

Related articles

Centre seeking answers to queries on ILP: Paul

SHILLONG, April 4: Amid the long-pending demand to implement the Inner Line Permit in Meghalaya, the Centre has...

My suspension from VPP was ‘premeditated’, says Adelbert

SHILLONG, April 4: North Shillong MLA Adelbert Nongrum on Friday said his suspension from the Voice of the...

All-party committee to consult stakeholders on railway projects

Hynniewtrep land will burn if govt brings rlys, pressure groups warn SHILLONG, April 4: The all-party committee headed by...

HYC threatens to block NEIGRIHMS recruitment

SHILLONG, April 4: The Hynniewtrep Youth Council (HYC) on Friday announced that it will not allow NEIGRIHMS to...